Submitted by Anonymous (not verified) on 8 August 2023 - 15:14
Human medicines European public assessment report (EPAR): Trecondi, treosulfan, Hematopoietic Stem Cell Transplantation, Date of authorisation: 20/06/2019, Revision: 4, Status: Authorised
Source: